1-7 of 7
Catherine B. Meador
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 6560: Cell-free RNA analysis for non-invasive cancer detection and characterization

Monica C. Nesselbush, Bogdan A. Luca, Young-Jun Jeon, Isabel Jabara, Catherine B. Meador, Michael S. Binkley, Nova Xu, Angela B. Hui, Andrea Garofalo, William Y. Shi, Kevin J. Liu, Takeshi Sugio, Noah Kastelowitz, Emily G. Hamilton, Rene F. Bonilla, Yi Peng Wang, Alice Jiang, Brianna Lau, Jordan Eichholz, Mandeep Banwait, Joseph Schroers-Martin, Jan Boegeholz, Daniel A. King, Mohammad S. Esfahani, Tyler Raclin, Robert Tibshirani, Sandy Srinivas, Viswam S. Nair, James M. Isbell, Bob T. Li, Zofia Piotrowska, Lecia V. Sequist, Aaron N. Hata, Joel W. Neal, Heather A. Wakelee, Andrew J. Gentles, Ash A. Alizadeh, Maximilian Diehn
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 6560.
https://doi.org/10.1158/1538-7445.AM2024-6560
Published: 22 March 2024
View article titled, Abstract 6560: Cell-free RNA analysis for non-invasive cancer detection and characterization
Journal Articles

Abstract 1025: Clinical outcomes and differential tumor immune microenvironment in patients with small cell lung cancer and paraneoplastic syndromes

Wade T. Iams, Eileen Shiuan, Catherine B. Meador, Marc Roth, Jennifer Bordeaux, Christine Vaupel, Lucy L. Wang, Joseph T. Schneider, Jeremy L. Warner, Zhiguo Zhao, Christine M. Lovly
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 1025.
https://doi.org/10.1158/1538-7445.AM2018-1025
Published: 01 July 2018
View article titled, Abstract 1025: Clinical outcomes and differential tumor immune microenvironment in patients with small cell lung cancer and paraneoplastic syndromes
Journal Articles

Abstract 3160: Sustained MAPK activation as a mechanism of resistance to osimertinib plus selumetinib in models of EGFR-mutant cancer

David Westover, Catherine B. Meador, Eiki Ichihara, Hayden F. Byrd, Cath Eberlein, Yingjun Yan, Darren A. Cross, Christine M. Lovly
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 3160.
https://doi.org/10.1158/1538-7445.AM2017-3160
Published: 01 July 2017
View article titled, Abstract 3160: Sustained MAPK activation as a mechanism of resistance to osimertinib plus selumetinib in models of <em>EGFR</em>-mutant cancer
Journal Articles

Abstract 4949: Longitudinal monitoring of cell-free DNA in patients with small cell lung cancer reveals dynamic insights into treatment efficacy and disease relapse

Christine M. Lovly, Karinna Almodovar, Wade T. Iams, Catherine B. Meador, Sally York, Leora Horn, Christopher K. Raymond, Jennifer Hernandez, Lee P. Lim
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 4949.
https://doi.org/10.1158/1538-7445.AM2017-4949
Published: 01 July 2017
View article titled, Abstract 4949: Longitudinal monitoring of cell-free DNA in patients with small cell lung cancer reveals dynamic insights into treatment efficacy and disease relapse
Journal Articles

SFK/FAK Signaling Attenuates Osimertinib Efficacy in Both Drug-Sensitive and Drug-Resistant Models of EGFR-Mutant Lung Cancer

Eiki Ichihara, David Westover, Catherine B. Meador, Yingjun Yan, Joshua A. Bauer, Pengcheng Lu, Fei Ye, Amanda Kulick, Elisa de Stanchina, Robert McEwen, Marc Ladanyi, Darren Cross, William Pao, Christine M. Lovly
Journal: Cancer Research
Series: Author Choice
Cancer Res (2017) 77 (11): 2990–3000.
https://doi.org/10.1158/0008-5472.CAN-16-2300
Published: 31 May 2017
View article titled, SFK/FAK Signaling Attenuates Osimertinib Efficacy in Both Drug-Sensitive and Drug-Resistant Models of EGFR-Mutant Lung Cancer
Open the PDF for SFK/FAK Signaling Attenuates Osimertinib Efficacy in Both Drug-Sensitive and Drug-Resistant Models of EGFR-Mutant Lung Cancer in another window
Includes: Supplementary data
Journal Articles

EPHA2 Blockade Overcomes Acquired Resistance to EGFR Kinase Inhibitors in Lung Cancer

Katherine R. Amato, Shan Wang, Li Tan, Andrew K. Hastings, Wenqiang Song, Christine M. Lovly, Catherine B. Meador, Fei Ye, Pengcheng Lu, Justin M. Balko, Daniel C. Colvin, Justin M. Cates, William Pao, Nathanael S. Gray, Jin Chen
Journal: Cancer Research
Cancer Res (2016) 76 (2): 305–318.
https://doi.org/10.1158/0008-5472.CAN-15-0717
Published: 14 January 2016
View article titled, EPHA2 Blockade Overcomes Acquired Resistance to EGFR Kinase Inhibitors in Lung Cancer
Open the PDF for EPHA2 Blockade Overcomes Acquired Resistance to EGFR Kinase Inhibitors in Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical Models

Catherine A. Eberlein, Daniel Stetson, Aleksandra A. Markovets, Katherine J. Al-Kadhimi, Zhongwu Lai, Paul R. Fisher, Catherine B. Meador, Paula Spitzler, Eiki Ichihara, Sarah J. Ross, Miika J. Ahdesmaki, Ambar Ahmed, Laura E. Ratcliffe, Elizabeth L. Christey O'Brien, Claire H. Barnes, Henry Brown, Paul D. Smith, Jonathan R. Dry, Garry Beran, Kenneth S. Thress, Brian Dougherty, William Pao, Darren A.E. Cross
Journal: Cancer Research
Series: Author Choice
Cancer Res (2015) 75 (12): 2489–2500.
https://doi.org/10.1158/0008-5472.CAN-14-3167
Published: 14 June 2015
View article titled, Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical Models
Open the PDF for Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical Models in another window
Includes: Supplementary data